Style | Citing Format |
---|---|
MLA | Khanmohammadi S, et al.. "Lymphoma in the Setting of Autoimmune Diseases: A Review of Association and Mechanisms." Critical Reviews in Oncology/Hematology, vol. 150, no. , 2020, pp. -. |
APA | Khanmohammadi S, Shabani M, Tabary M, Rayzan E, Rezaei N (2020). Lymphoma in the Setting of Autoimmune Diseases: A Review of Association and Mechanisms. Critical Reviews in Oncology/Hematology, 150(), -. |
Chicago | Khanmohammadi S, Shabani M, Tabary M, Rayzan E, Rezaei N. "Lymphoma in the Setting of Autoimmune Diseases: A Review of Association and Mechanisms." Critical Reviews in Oncology/Hematology 150, no. (2020): -. |
Harvard | Khanmohammadi S et al. (2020) 'Lymphoma in the Setting of Autoimmune Diseases: A Review of Association and Mechanisms', Critical Reviews in Oncology/Hematology, 150(), pp. -. |
Vancouver | Khanmohammadi S, Shabani M, Tabary M, Rayzan E, Rezaei N. Lymphoma in the Setting of Autoimmune Diseases: A Review of Association and Mechanisms. Critical Reviews in Oncology/Hematology. 2020;150():-. |
BibTex | @article{ author = {Khanmohammadi S and Shabani M and Tabary M and Rayzan E and Rezaei N}, title = {Lymphoma in the Setting of Autoimmune Diseases: A Review of Association and Mechanisms}, journal = {Critical Reviews in Oncology/Hematology}, volume = {150}, number = {}, pages = {-}, year = {2020} } |
RIS | TY - JOUR AU - Khanmohammadi S AU - Shabani M AU - Tabary M AU - Rayzan E AU - Rezaei N TI - Lymphoma in the Setting of Autoimmune Diseases: A Review of Association and Mechanisms JO - Critical Reviews in Oncology/Hematology VL - 150 IS - SP - EP - PY - 2020 ER - |